Abstract
Cancer and chemoradiotherapy have a significant adverse impact on the quality of life (QOL) of cancer patients. With the advent of new and more effective cancer therapies, patients with cancer are surviving longer than in the past. This has led to increased importance for maintaining good QOL in cancer patients. Therefore, a great emphasis has been placed on QOL assessments in cancer clinical trials and in clinical practice through the administration of QOL instruments such as the European Organization for Research and Treatment of Cancer (EORTC) and the Functional Assessment of Chronic Illness Therapy (FACIT) instruments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
